---
figid: PMC5354697__oncotarget-08-10748-g003
figlink: /pmc/articles/PMC5354697/figure/F3/
number: Figure 3
caption: A, PD-L1 expressed on tumor cells binds to PD-1 on T-cells recruiting a phosphatase,
  SHP-2, which blocks the PI3K pathway and leads to down-regulation of T-cell survival
  proteins, including IFN-γ, BCL-XL and IL-2, resulting in T-cell anergy or “exhaustion”,
  thereby “braking” the T-cell immune response. B, The anti-PD-1 antibodies block
  the PD-1 pathway “release the brake” preventing suppression of the anti-tumor response.
pmcid: PMC5354697
papertitle: 'Magic year for multiple myeloma therapeutics: Key takeaways from the
  ASH 2015 annual meeting.'
reftext: Kejie Zhang, et al. Oncotarget. 2017 Feb 7;8(6):10748-10759.
pmc_ranked_result_index: '29721'
pathway_score: 0.9729787
filename: oncotarget-08-10748-g003.jpg
figtitle: 'Magic year for multiple myeloma therapeutics: Key takeaways from the ASH
  2015 annual meeting'
year: '2017'
organisms: Homo sapiens
ndex: 3371702a-dec4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5354697__oncotarget-08-10748-g003.html
  '@type': Dataset
  description: A, PD-L1 expressed on tumor cells binds to PD-1 on T-cells recruiting
    a phosphatase, SHP-2, which blocks the PI3K pathway and leads to down-regulation
    of T-cell survival proteins, including IFN-γ, BCL-XL and IL-2, resulting in T-cell
    anergy or “exhaustion”, thereby “braking” the T-cell immune response. B, The anti-PD-1
    antibodies block the PD-1 pathway “release the brake” preventing suppression of
    the anti-tumor response.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRG
  - PDCD1
  - BCL2L1
  - PDCD1LG2
  - TRD
  - CD274
  - TRA
  - PIK3R6
  - IL2
  - AKT2
  - PIK3CA
  - TRB
  - PIK3CB
  - AKT1
  - PTPN11
  - PIK3R3
  - AKT3
  - PIK3CD
  - PIK3R5
  - PIK3R4
  - PIK3CG
genes:
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: BCL-XL,IL-2
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: PD-L1/L2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: PD-L1/L2
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: BCL-XL,IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3k
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases: []
---
